These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 2948492

  • 1. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P, Piepkorn M, Linker A.
    Biochem J; 1986 Jul 15; 237(2):573-81. PubMed ID: 2948492
    [Abstract] [Full Text] [Related]

  • 2. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
    Carlson TH, Kolman MR, Piepkorn M.
    Blood Coagul Fibrinolysis; 1995 Jul 15; 6(5):474-80. PubMed ID: 8589216
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulant properties in vitro of heparan sulphates.
    Hubbard AR, Jennings CA, Barrowcliffe TW.
    Thromb Res; 1984 Sep 01; 35(5):567-76. PubMed ID: 6237461
    [Abstract] [Full Text] [Related]

  • 4. Isolation of heparan sulfates with antithrombin III affinity and anticoagulant potency from BALB/c 3T3, B16.F10 melanoma, and cutaneous fibrosarcoma cell lines.
    Piepkorn M, Hovingh P, Hentschel WM.
    Biochem Biophys Res Commun; 1988 Feb 29; 151(1):327-32. PubMed ID: 2964821
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF, Ellis V, Shah N, Kakkar V.
    Biochem J; 1989 Sep 01; 262(2):651-8. PubMed ID: 2529852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen.
    Horner AA.
    Biochem J; 1990 Mar 01; 266(2):553-9. PubMed ID: 2138457
    [Abstract] [Full Text] [Related]

  • 10. Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates.
    Casu B, Johnson EA, Mantovani M, Mulloy B, Oreste P, Pescador R, Prino G, Torri G, Zoppetti G.
    Arzneimittelforschung; 1983 Mar 01; 33(1):135-42. PubMed ID: 6219676
    [Abstract] [Full Text] [Related]

  • 11. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin.
    Dawes J.
    Anal Biochem; 1988 Oct 01; 174(1):177-86. PubMed ID: 3218731
    [Abstract] [Full Text] [Related]

  • 12. Anticoagulant heparin-like glycosaminoglycans on endothelial cell surface.
    Shimada K, Kobayashi M, Kimura S, Nishinaga M, Takeuchi K, Ozawa T.
    Jpn Circ J; 1991 Oct 01; 55(10):1016-21. PubMed ID: 1744977
    [Abstract] [Full Text] [Related]

  • 13. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J.
    Haemostasis; 1986 Oct 01; 16(2):82-6. PubMed ID: 3710297
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.
    Hurst RE, Poon MC, Griffith MJ.
    J Clin Invest; 1983 Sep 01; 72(3):1042-5. PubMed ID: 6688430
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.
    Nishinaga M, Ozawa T, Shimada K.
    J Clin Invest; 1993 Sep 01; 92(3):1381-6. PubMed ID: 8376590
    [Abstract] [Full Text] [Related]

  • 17. Modulation of glycosaminoglycan production and antithrombin III binding by cultured aortic endothelial cells treated with 4-methylumbelliferyl-beta-D-xyloside.
    Shimada K, Ozawa T.
    Arteriosclerosis; 1987 Sep 01; 7(6):627-36. PubMed ID: 3689206
    [Abstract] [Full Text] [Related]

  • 18. Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells.
    Hosseini G, Liu J, de Agostini AI.
    J Biol Chem; 1996 Sep 06; 271(36):22090-9. PubMed ID: 8703018
    [Abstract] [Full Text] [Related]

  • 19. A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities.
    Liu S, Zhou F, Höök M, Carson DD.
    Proc Natl Acad Sci U S A; 1997 Mar 04; 94(5):1739-44. PubMed ID: 9050848
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP.
    J Pharmacol Exp Ther; 1982 Feb 04; 220(2):406-10. PubMed ID: 7057400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.